Skip to main content

What the FDA labels say about taking them together

Epinephrine and sufentanil

Sufentanil's FDA label of June 1, 2026 names epinephrine in its warnings and precautions section; the epinephrine labels PlainMeds reads (4) do not name sufentanil. The sufentanil label: “If volume expansion with fluids plus other countermeasures do not correct hypotension, consider administration of pressor agents other than epinephrine.”

Check it at the source: the epinephrine FDA label on DailyMed (effective July 13, 2026, A-S Medication Solutions); the sufentanil FDA label on DailyMed (effective June 1, 2026, Hospira, Inc.).

What does the epinephrine label say about sufentanil?

Epinephrine's label (effective July 13, 2026) and its 3 other brand-application labels do not name sufentanil in these sections. A label lists what its studies and reports found; it is not a complete list.

Source: FDA drug label (Epinephrine), A-S Medication Solutions, effective July 13, 2026 (SPL set 6e811e28-0199-4df7-a916-5940c632401d), via openFDA; the full label on DailyMed

What does the sufentanil label say about epinephrine?

Sufentanil label, warnings and precautions

If volume expansion with fluids plus other countermeasures do not correct hypotension, consider administration of pressor agents other than epinephrine.

Source: FDA drug label (Sufentanil Citrate), Hospira, Inc., effective June 1, 2026 (SPL set 20293943-46ff-4345-1aa4-929b4e017a25), via openFDA; the full label on DailyMed

These are the labels' own sentences. PlainMeds does not grade interactions; a pharmacist or prescriber can say what they mean for one person's medicines.

Both medicines on the record

16Epinephrine generic labelers
1Sufentanil generic labelers
EpinephrineSufentanil
Labeled forAsthman/a
Boxed warningNoYes
Pharmacy cost (NADAC)$123.51 per unit 0.15 mg auto-injctn/a
Shortage nowA presentation being discontinuedIn shortage

Source: FDA NDC Directory, CMS NADAC of October 7, 2026 and the FDA Drug Shortage Database (FDA files October 8, 2026)

What next?